Market Research Logo

Mexico Pharmaceuticals & Healthcare Q4 2019

Mexico Pharmaceuticals & Healthcare Q4 2019

Key View:

Mexico’s new public drug procurement system will create challenges for pharmaceutical operators across the supplychain, requiring business models to adapt to new drug distribution schemes and pricing pressure. The separation of drugdistribution from the direct purchase of medicines, which is aimed at reducing drug distribution costs and generating overallsavings, will increase operational risks in the near term. While the recent announcement of additional public funds to purchasemedicines will create opportunities for pharmaceutical companies in the near term, we continue to forecast decelerating growth inpharmaceutical spending over the coming years as the incumbent government looks to contain healthcare spending.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
Mexico Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Boehringer Ingelheim
Genomma Labs
Mexico Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook